日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The oncolytic adenovirus Ad-TD-nsIL12 in primary or progressive pediatric IDH wild-type diffuse intrinsic pontine glioma results of two phase I clinical trials.

溶瘤腺病毒 Ad-TD-nsIL12 治疗原发性或进展性儿童 IDH 野生型弥漫性内生性脑桥胶质瘤的两项 I 期临床试验结果

Qian Xiao, Ning Weihai, Yang Jingjing, Dunmall Louisa Chard, Pandha Hardev S, Shang Guanjie, Guo Yuduo, Zhang Dongxu, Qu Yanming, Wang Haoran, Gu Chunyu, Zhang Mingshan, Wang Yaohe, Wang Shengdian, Zhang Hongwei

Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumors

一项针对晚期实体瘤患者的静脉注射柯萨奇病毒A21(V937)联合或不联合帕博利珠单抗的安全性、药代动力学和初步疗效的1期开放标签剂量递增研究

Rudin, Charles M; Pandha, Hardev S; Zibelman, Matthew; Akerley, Wallace L; Harrington, Kevin J; Day, Daphne; Hill, Andrew G; O'Day, Steven J; Clay, Timothy D; Wright, Gavin M; Jennens, Ross R; Gerber, David E; Rosenberg, Jonathan E; Ralph, Christy; Campbell, David C; Curti, Brendan D; Merchan, Jaime R; Ren, Yixin; Schmidt, Emmett V; Guttman, Lisa; Gupta, Sumati

Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI-001 in in vitro Models of Prostate Cancer Drug Resistance

在体外前列腺癌耐药模型中,混合型雄激素受体抑制剂的疗效优于恩扎卢胺和EPI-001。

Nicolescu, Radu Costin Bizga; Maylin, Zoe R; Pérez-Areales, Francisco Javier; Iegre, Jessica; Pandha, Hardev S; Asim, Mohammad; Spring, David R

Molecular characterization of renal cell carcinoma tumors from a phase III anti-angiogenic adjuvant therapy trial

来自 III 期抗血管生成辅助治疗试验的肾细胞癌肿瘤的分子特征分析

Motzer, Robert J; Martini, Jean-François; Mu, Xinmeng J; Staehler, Michael; George, Daniel J; Valota, Olga; Lin, Xun; Pandha, Hardev S; Ching, Keith A; Ravaud, Alain

Downstream of the HOX genes: Explaining conflicting tumour suppressor and oncogenic functions in cancer

HOX基因下游:解释癌症中相互矛盾的抑癌和致癌功能

Morgan, Richard; Hunter, Keith; Pandha, Hardev S

Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis

舒尼替尼辅助治疗高危肾细胞癌患者的III期临床试验:探索性药物基因组学分析

George, Daniel J; Martini, Jean-Francois; Staehler, Michael; Motzer, Robert J; Magheli, Ahmed; Donskov, Frede; Escudier, Bernard; Li, Sherry; Casey, Michelle; Valota, Olga; Laguerre, Brigitte; Pantuck, Allan J; Pandha, Hardev S; Patel, Anup; Lechuga, Maria; Ravaud, Alain

Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissues

能够维持微血管功能的基因改造慢病毒可以保护正常组织免受晚期辐射损伤。

Khan, Aadil A; Paget, James T; McLaughlin, Martin; Kyula, Joan N; Wilkinson, Michelle J; Pencavel, Timothy; Mansfield, David; Roulstone, Victoria; Seth, Rohit; Halle, Martin; Somaiah, Navita; Boult, Jessica K R; Robinson, Simon P; Pandha, Hardev S; Vile, Richard G; Melcher, Alan A; Harris, Paul A; Harrington, Kevin J

Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results

肾切除术后高危肾细胞癌辅助治疗:舒尼替尼治疗的亚组分析和更新的总生存期结果

Motzer, Robert J; Ravaud, Alain; Patard, Jean-Jacques; Pandha, Hardev S; George, Daniel J; Patel, Anup; Chang, Yen-Hwa; Escudier, Bernard; Donskov, Frede; Magheli, Ahmed; Carteni, Giacomo; Laguerre, Brigitte; Tomczak, Piotr; Breza, Jan; Gerletti, Paola; Lechuga, Mariajose; Lin, Xun; Casey, Michelle; Serfass, Lucile; Pantuck, Allan J; Staehler, Michael

Induction of trismus by sunitinib and pazopanib in metastatic renal cell carcinoma

舒尼替尼和帕唑帕尼在转移性肾细胞癌中诱发牙关紧闭

Iyer, Ridhima; Montgomery, Bruce; Pandha, Hardev S

Targeting HOX/PBX dimers in cancer

靶向HOX/PBX二聚体治疗癌症

Morgan, Richard; El-Tanani, Mohamed; Hunter, Keith D; Harrington, Kevin J; Pandha, Hardev S